Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Debt Ratio (2024 - 2026)

Revium Rx's (RVRC) quarterly Debt Ratio came in at 0.0 in Q2 2026, up 16.77% quarter-over-quarter from 0.0 in Q4 2025.

Analysis

Revium Rx (RVRC) Debt Ratio (2024 - 2026) Analysis & Trends

Revium Rx has disclosed Debt Ratio across 3 years of filings, most recently posting 0.0 for Q2 2026.

  • In Q2 2026, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2026 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.0, down 98.87% from the prior year.
  • Debt Ratio came in at 0.0 for Q2 2026 at Revium Rx, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.01 in Q4 2024 to a low of 0.0 in Q4 2025.
  • Average Debt Ratio over 3 years is 0.0, with a median of 0.0 recorded in 2026.
  • The largest YoY upside for Debt Ratio was 98.87% in 2025 against a maximum downside of 98.87% in 2025.
  • Over 3 years, Debt Ratio stood at 0.01 in 2024, then slumped by 98.87% to 0.0 in 2025, then climbed by 16.77% to 0.0 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q2 2026, 0.0 in Q4 2025, and 0.01 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 0.66
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 0.05
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 0.05
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 0.25
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 0.26
10 Revium Rx 86.84 Mn 85.34 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.00
Dec 31, 2024 0.01